Related Experiment Video
Updated: May 12, 2026
06:40
The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Current perspectives in NSAID-induced gastropathy.
Mau Sinha1, Lovely Gautam, Prakash Kumar Shukla
1Department of Biophysics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Mediators of Inflammation
|April 12, 2013
Summary
Nonsteroidal anti-inflammatory drugs (NSAIDs) offer pain relief but cause gastrointestinal issues. This review examines NSAID complications and explores new strategies for safer anti-inflammatory drugs with better stomach protection.
Area of Science:
- Pharmacology
- Gastroenterology
- Drug Development
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for their pain-relieving and anti-inflammatory properties.
- However, NSAIDs are linked to significant gastrointestinal (GI) complications, including injury and ulceration.
- Current mitigation strategies, such as COX-2 inhibitors and acid suppressants, have limitations in efficacy and safety.
Purpose of the Study:
- To review the mechanism of action of NSAIDs.
- To detail the critical gastrointestinal complications associated with NSAID use.
- To analyze novel strategies for developing NSAIDs with improved gastrointestinal safety.
Main Methods:
- Literature review of NSAID mechanisms.
- Analysis of studies on NSAID-induced gastrointestinal injury.
- Evaluation of current and emerging preventive measures and drug development strategies.
Main Results:
- NSAIDs exert their effects through mechanisms that also lead to direct GI mucosal damage.
- Gastrointestinal complications represent a major clinical challenge in NSAID therapy.
- Existing protective strategies are imperfect, highlighting the need for improved drug design.
Conclusions:
- Understanding NSAID mechanisms is crucial for addressing GI side effects.
- Development of novel NSAIDs must prioritize effective gastrointestinal protection alongside therapeutic benefits.
- Future research should focus on innovative approaches to minimize NSAID-related GI morbidity.
Related Concept Videos
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
01:28Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
01:25Peptic Ulcer Disease III: Clinical Manifestations and Complications
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:17Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
01:23Gastritis III: Clinical Manifestations and Management
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...